Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Wegovy
Biotech
A look at the R&D landscape in obesity, led by GLP-1s
If you’re feeling like the obesity pipeline filled up overnight, you’re not alone. A new analysis from IQVIA takes a look at the drugs in development.
Annalee Armstrong
,
Gabrielle Masson
Mar 19, 2024 8:00am
Another win for Novo in obesity as early oral med beats Wegovy
Mar 7, 2024 9:27am
Vivani's exenatide implant boosts weight loss as well as Wegovy
Mar 1, 2024 10:00am
Novo Nordisk unveils new US hub as R&D investments soar
Feb 29, 2024 5:00am
Mikael Dolsten preps Pfizer's entry into obesity's 2nd wave
Feb 13, 2024 9:50am
Novo Holdings plans to ramp up dealmaking amid Wegovy windfall
Jan 19, 2024 9:30am